| Literature DB >> 30519579 |
Jorge Marin-Puyalto1,2,3,4, Alba Gomez-Cabello2,3,4,5,6, Alejandro Gonzalez-Agüero1,2,3,4,6, Alejandro Gomez-Bruton1,2,3,4,6, Angel Matute-Llorente1,2,3,4,6, Jose A Casajús1,2,3,4,6, German Vicente-Rodríguez1,2,3,4,6.
Abstract
Whole-body vibration (WBV) intervention studies and reviews have been increasing lately. However, the results regarding its effects on bone tissue in different populations are still inconclusive. The goal of this overview was to summarize systematic reviews assessing the effects of WBV training on bone parameters. Three electronic databases were scanned for systematic reviews and meta-analyses evaluating the effects of WBV on bone tissue. The search had no time restrictions and was limited to articles written in English. Vibration protocols and the main bone parameters included in each review were extracted. Methodological quality was assessed and analyses were conducted stratifying by age. 17 reviews and meta-analyses fulfilled the inclusion criteria. No increase or small improvements in bone mineral density (BMD) after WBV interventions were observed in reviews regarding postmenopausal women. One intervention study regarding young adults was included and reported no bone-related benefits from WBV. Most reviews including children and adolescents with compromised bone mass showed an improvement of BMD at lower limbs, lumbar spine, and whole body. In conclusion, WBV interventions seem to help children and adolescents with compromised bone mass to increase their BMD, but these improvements are limited in postmenopausal women and there is insufficient evidence for young adults. Further research is also needed to identify the ideal parameters of WBV training focused on bone health.Entities:
Mesh:
Year: 2018 PMID: 30519579 PMCID: PMC6241242 DOI: 10.1155/2018/5178284
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow chart diagram of the review selection.
Summary of review characteristics.
| Author, year | Aim | Search strategy | Number of WBV bone-related trials included | Comparison interventions | Duration of the interventions | Bone-related outcomes for which data were reported |
|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
| Merriman, 2009 | To assess the effectiveness of WBV on bone density, muscle performance, balance, and functional mobility | MEDLINE (1950-2007), CINAHL (1982-2007) | 5 (251) | Control, placebo device, fitness exercise (<=40 min, 3/week), resistance exercise, physical therapy, walking | 6-52 weeks | BMD (whole body, total hip, proximal femur, lumbar spine, cortical tibia) |
|
| ||||||
| Mikhael, 2010 | To examine the effect of WBV on muscle or bone morphology and function | Medline, SPORTDiscus, AusportMed, CINAHL, AMED, WoS, Scopus | 3 (153) | Control, resistance, exercise, placebo device | 6-52 weeks | BMC (lumbar spine) |
|
| ||||||
| Lau, 2011 | To determine whether WBV improves BMD and leg muscle strength | MEDLINE, CINAHL, EMBASE, PEDro, PubMed, Science Citation Index | 6 (398) | Control, active exercise | 6 weeks-18 months | BMD (total hip, lumbar spine) |
|
| ||||||
| Pollock, 2012 | To assess studies which have investigated the outcome of repeated exposure to WBV | WoS, PubMed, EMBASE, CINAHL, PEDro, Cochrane Library | 10 (719) | Control, placebo device, fitness exercise, walking, resistance training, wellness program | 6-52 weeks | BMD (whole body, total hip, proximal femur, radius, lumbar spine) |
|
| ||||||
| Gómez-Cabello, 2012 | To assess the effects of different training programmes in bone mass | MEDLINE & CENTRAL | 10 (740) | Control, aerobic training, strength training and multicomponent training | 6-18 months | BMC (whole body) |
|
| ||||||
| Sitjá-Rabert, 2012 | To analyze the efficacy and safety of WBV training | MEDLINE, EMBASE, CENTRAL, CINAHL, PeDro, PsychInfo | 5 (247) | Control, exercise group (various modalities) | 6-52 weeks | BMD (femoral neck, lumbar spine) |
|
| ||||||
| Ma, 2016 | To evaluate the musculoskeletal effect of WBV | EMBASE, PubMed, Cochrane Central Register of Controlled Trials, ISI Web of Science, CNKI | 8 (1014) | Control, resistance training, placebo device, walking | 6-18 months | BMD (femoral neck, lumbar spine) |
|
| ||||||
| Oliveira, 2016 | To analyze clinical trials that verified the effects of WBV on BMD in postmenopausal women | PubMed, Web of Science, LILACS, The Cochrane Library, PEDro | 17 (1833) | Control, exercise group (various modalities) | 6-18 months | BMD (lumbar spine, total hip, femoral neck, trochanter, Ward's area, tibia, radius) |
|
| ||||||
| Dionello, 2016 | To review recent literature and highlight novel findings on the effect of WBV exercise on the BMD in women with postmenopausal osteoporosis without medications | PubMed, PEDro | 11 (922) | Control, placebo device, wellness program, resistance training | 2-18 months | BMD (whole body, lumbar spine, total hip, femoral neck) |
|
| ||||||
| Luo, 2016 | To conduct a comprehensive quantitative analysis of WBV in patients with postmenopausal osteoporosis | MEDLINE, CINAHL, PEDro, CENTRAL | 9 (625) | Control, wellness program, walking, resistance training | 12-48 weeks | BMD (lumbar spine, femoral neck, total hip, Ward's triangle) |
|
| ||||||
| Jepsen, 2017 | To address if WBV in adults over 50 years of age could affect the estimates of bone mass, architecture, and turnover biomarkers | PubMed, EMBASE, Cochrane | 12 (1618) | Control, placebo device, exercise, wellness program | 3-24 months | BMD (femoral neck, total hip, lumbar spine) |
|
| ||||||
|
| ||||||
|
| ||||||
| Matute, 2014 | To summarize the current literature regarding the effects of WBV on health-related fitness parameters (children and adolescents with disabilities) | MEDLINE (PubMed), SPORTDiscus, EMBASE | 8 (338) | Control | 8-52 weeks | BMC (whole body, lumbar spine) |
|
| ||||||
| Saquetto, 2018 | To verify the effects of WBV training on the muscle strength, bone mineral parameters, balance, and body composition of children and adolescents with Down's Syndrome | MEDLINE, LILACS, SciELO, PEDro, Cochrane | 1 (25) | Control | 20 weeks | BMC (whole body, lumbar spine) |
|
| ||||||
|
| ||||||
|
| ||||||
| Madou, 2008 | To critique the research that has used WBV with special populations (elderly, postmenopausal women, and neurological patients) | ProQuest, IngentaConnect, Meditext, MEDLINE, Proquest5000, PubMed, SPORTDiscus, WoS, Health and Medical Complete, Google Scholar | 2 (99) | Control, resistance training | 6-8 months | BMD (whole body, total hip, lumbar spine) |
|
| ||||||
| Rehn, 2008 | To systematically review controlled studies that have explored the effects of WBV on BMD in humans | PubMed, Cinahl, Embase, Pedro, Amed | 8 (383) | Control, walking, placebo device, strength training | 3-52 weeks | BMD (total hip, femoral neck, lumbar spine, tibia) |
|
| ||||||
| Slatkovska, 2010 | To analyze the effects of WBV on BMD | MEDLINE, EMBASE, CINAHL, Cochrane, SPORTDiscus, ProQuest Dissertations, Theses Canada Portal | 8 (328) | Control, resistance training, placebo device, walking | 6-52 weeks | BMD (total hip, lumbar spine) |
|
| ||||||
| Wysocki, 2011 | To provide an overview of WBV therapy for the prevention and treatment of osteoporosis | MEDLINE, Cochrane Library, ACMD, CINAHL, CSA Physical Education Index, WoS, Physiotherapy Evidence Database, Academic Search Premier + gray literature | 9 | Control, walking, resistance training, wellness program, placebo device, | 8-72 weeks | BMD (whole body, lumbar spine, total hip, femoral neck, trochanter, radius, tibia) |
WBV: whole body vibration; BMC: bone mineral content; BMD: bone mineral density.
Methodological quality of the included reviews according to the AMSTAR tool.
| “A priori” design | Duplicate study selection | Comprehensive search | Status of literature as inclusion criterion | List of studies (included and excluded) | Characteristics of studies | Scientific quality assessed | Scientific quality considered in conclusions | Methods to combine findings | Publication bias assessed | Conflict of interest | Total (out of 11) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rehn, 2008 | Y | Y | Y | Y | N | Y | Y | Y | NA | N | N |
|
| Madou, 2008 | Y | CA | Y | Y | N | Y | Y | N | NA | N | N |
|
| Merriman, 2009 | Y | CA | Y | N | N | Y | Y | Y | NA | N | N |
|
| Slatkovska, 2010 | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | Y |
|
| Mikhael, 2010 | Y | CA | Y | Y | N | Y | Y | N | NA | N | Y |
|
| Lau, 2011 | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | N |
|
| Wysocki, 2011 | Y | Y | Y | Y | N | Y | N | CA | NA | N | Y |
|
| Pollock, 2012 | Y | CA | Y | Y | N | Y | Y | Y | NA | N | N |
|
| Gómez-Cabello, 2012 | Y | Y | Y | Y | N | Y | N | CA | NA | N | Y |
|
| Sitjá-Rabert, 2012 | Y | Y | Y | Y | N | Y | Y | N | Y | N | Y |
|
| Matute, 2014 | Y | Y | Y | Y | N | Y | Y | Y | NA | N | Y |
|
| Ma, 2016 | Y | Y | Y | Y | N | Y | Y | N | Y | N | Y |
|
| Oliveira, 2016 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
|
| Dionello, 2016 | Y | Y | Y | N | N | Y | N | CA | NA | N | Y |
|
| Luo, 2016 | Y | Y | Y | Y | N | Y | Y | Y | Y | N | Y |
|
| Jepsen, 2017 | Y | Y | Y | Y | N | Y | Y | Y | Y | N | Y |
|
| Saquetto, 2018 | Y | Y | Y | N | N | Y | Y | N | NA | N | Y |
|
Y: yes; N: no; CA: cannot answer; NA: not applicable.
Overlap within reviews.
| Author, year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Madou et al., 2008 |
| 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 1 | 2 | 1 | 0 |
| 2. Rehn et al., 2008 |
| 5 | 8 | 3 | 5 | 6 | 5 | 5 | 5 | 2 | 4 | 5 | 1 | 3 | 2 | 0 | |
| 3. Merriman et al., 2009 |
| 5 | 3 | 5 | 5 | 5 | 5 | 5 | 0 | 4 | 5 | 1 | 3 | 2 | 0 | ||
| 4. Slatkovska et al., 2010 |
| 3 | 5 | 6 | 5 | 5 | 5 | 2 | 4 | 5 | 1 | 3 | 2 | 0 | |||
| 5. Mikhael et al., 2010 |
| 3 | 3 | 3 | 3 | 3 | 0 | 2 | 3 | 0 | 1 | 1 | 0 | ||||
| 6. Lau et al., 2011 |
| 6 | 6 | 6 | 5 | 0 | 5 | 6 | 2 | 4 | 3 | 0 | |||||
| 7. Wysocki et al., 2011 |
| 8 | 7 | 5 | 1 | 5 | 6 | 3 | 4 | 3 | 0 | ||||||
| 8. Pollock et al., 2012 |
| 9 | 5 | 0 | 5 | 7 | 4 | 5 | 4 | 0 | |||||||
| 9. Gómez-Cabello et al., 2012 |
| 5 | 0 | 6 | 8 | 4 | 6 | 5 | 0 | ||||||||
| 10. Sitjà-Rabert et al., 2012 |
| 0 | 4 | 5 | 1 | 3 | 2 | 0 | |||||||||
| 11. Matute-Llorente et al., 2014 |
| 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||
| 12. Ma et al., 2016 |
| 8 | 4 | 6 | 5 | 0 | |||||||||||
| 13. Oliveira et al., 2016 |
| 8 | 8 | 9 | 0 | ||||||||||||
| 14. Dionello et al., 2016 |
| 7 | 6 | 0 | |||||||||||||
| 15. Luo et al., 2016 |
| 6 | 0 | ||||||||||||||
| 16. Jepsen et al., 2017 |
| 0 | |||||||||||||||
| 17. Saquetto et al., 2018 |
| ||||||||||||||||
The values indicate the number of individual studies that are included in both reviews (row and column).
Bold characters show the number of RCTs for each review.
Corrected covered area: 16.8 (calculated as proposed by Pieper et al.).